Eswar Therapeutics

Chandigarh, India Founded: 2017 • Age: 9 yrs
Provision of pharmaceutical and nutritional products in India.

About Eswar Therapeutics

Eswar Therapeutics is a Healthcare company based in Chandigarh (India) founded in 2017. Provision of pharmaceutical and nutritional products in India. The company has 140 employees. Its Indian entity Eswar Therapeutics Private Limited reported revenue of β‚Ή54.06 Cr. Eswar Therapeutics offers products and services including Medications and Nutritional Supplements. Its focus areas include Nutraceuticals, Nutritional Supplements, Vitamins and Minerals and Pharmaceuticals.

Company details

Eswar Therapeutics is recognized as a leading pharmaceutical company in India, where high-quality branded and generic medications are provided across areas such as Diabetology, Cardiology, Gastroenterology, and Neurology, along with vitamins and minerals. A presence is established in 13 states and union territories, with expansions planned for additional regions. Employees are nurtured and motivated to drive excellence, while quality standards are maintained through commitments to innovation and integrity. Access to affordable medicines is ensured for patients globally, emphasizing technology and employee development.

Key Metrics
  • Annual Revenue
    ₹54.06 Cr

    FY 2025 · +24% YoY

  • Net Profit
    ₹1.29 Cr

    FY 2025 · 2% margin

  • EBITDA
    ₹2.74 Cr

    FY 2025 · 5% margin

  • Employee Count
    140

Products & Services of Eswar Therapeutics

Eswar Therapeutics offers a comprehensive portfolio of products and services, including Medications and Nutritional Supplements.

Medications
Pharmaceuticals

High-quality branded and generic medications are manufactured and distributed for therapeutic areas including Diabetology and Cardiology.

Nutritional Supplements
Nutraceuticals

Vitamins, minerals, and nutrients are provided to support health in various segments.

Board of directors of Eswar Therapeutics Private Limited (Eswar Therapeutics)

Eswar Therapeutics Private Limited is the primary company behind Eswar Therapeutics. The board of Eswar Therapeutics Private Limited currently have 3 directors; the longest-serving is Vikram Khungar, appointed in 2019. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vikram Khungar
DIN 06867915
Managing Director25 Jan 20197 yrs 9 moEswar Therapeutics Private Limited
Raj Khurana
DIN 07766128
Director01 Apr 20233 yrs 7 moEswar Therapeutics Private Limited
Kashmiri Lal Khunger
DIN 10391173
Director28 Nov 20232 yrs 11 moEswar Therapeutics Private Limited

Financials of Eswar Therapeutics

Figures of Eswar Therapeutics Private Limited, the primary company behind Eswar Therapeutics, for FY 2025. Revenue was ₹54.06 Cr (+24% year on year). Net profit was ₹1.29 Cr (2% margin). EBITDA was ₹2.74 Cr (5% margin). Revenue has grown at a compounded annual rate of +32% over three years and +25% over five years.

  • ₹54.06 CrRevenue · FY 2025 · +24% YoY
  • ₹1.29 CrNet profit · 2% margin
  • ₹2.74 CrEBITDA · 5% margin
  • ₹1 LakhPaid-up capital
  • 140Employees (provident fund records)
  • +32%Revenue CAGR, 3 years
  • +25%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Eswar Therapeutics Private Limited are on its company page.

Premium access

Detailed financial statements for Eswar Therapeutics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Eswar Therapeutics (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M5,180
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.21 B25,870
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Eswar Therapeutics

Eswar Therapeutics was founded in 2017.

Eswar Therapeutics is headquartered in Chandigarh, India.

Eswar Therapeutics has 140 employees.

The primary company behind Eswar Therapeutics, Eswar Therapeutics Private Limited, reported revenue of β‚Ή54.06 Cr for FY 2025, up 24% year on year.

Eswar Therapeutics is recognized as a leading pharmaceutical company in India, where high-quality branded and generic medications are provided across areas such as Diabetology, Cardiology, Gastroenterology, and Neurology, along with vitamins and minerals. A presence is established in 13 states and union territories, with expansions planned for additional regions. Employees are nurtured and motivated to drive excellence, while quality standards are maintained through commitments to innovation and integrity. Access to affordable medicines is ensured for patients globally, emphasizing technology and employee development.

Eswar Therapeutics offers Medications and Nutritional Supplements.

Eswar Therapeutics operates through Eswar Therapeutics Private Limited.

The legal entities of Eswar Therapeutics currently have 3 directors, including Kashmiri Lal Khunger, Vikram Khungar, Raj Khurana.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available